Atlas Trials

Newly Diagnosed Secondary or High Risk AML

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Newly Diagnosed Secondary or High Risk AML

RecordFirmDate
Clinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid Leukemia (NCT04230239)PETHEMA Foundation2019-12-26

Track Newly Diagnosed Secondary or High Risk AML automatically

Every clearance here is in the API, with alerts when new ones post.